The effectiveness of intranasal corticosteroids and antihistamines combination - mometasone furoate and azelastine hydrochloride nasal spray in adults with seasonal allergic rhinitis (The results of clinical trial)

Abstract

Background. Intranasal corticosteroids and antihistamines are the basis of pharmacotherapy of allergic rhinitis (AR). The aim of this study was to evaluate the efficacy, safety and tolerability of Momat Rhino Advance (fixed combination of azelastine hydrochloride 140 mcg + mometasone furoate 50 mcg) intranasal spray in seasonal rhinitis patients. Materials and methods. Momat Rhino Advance was administered within 14 days in adults with seasonal AR in comparison with the original azelastine hydrochloride and mometasone furoate, used in combination with each other from separate devices against nasal (TNSS) and non-nasal (TNNSS) rhinitis symptoms. In total, 220 patients 18-65 years old with moderate/severe seasonal AR, were randomized in an open, parallel-group, multicenter clinical trial conducted in 16 centers in the Russian Federation during the period from April to September 2014. Results and conclusion. As a result of the study a marked decreasing of nasal symptoms using scale TNSS (in 89,6% relatively to the initial visit, p

Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes

“…The SLR for clinical trial evidence identified 48 records from 42 studies across the indications of glaucoma/ocular hypertension (n = 10), 30,35,57,61,[66][67][68][69]81,134 hypertension (n = 6), 41,60,83,92,124,131 asthma (n = 7), 37,72,75,98,106,107,133 tuberculosis (n = 6), 28,32,79,91,123,125,132 HIV (n = 3), 48,108,128 and others. Twenty-six studies did not identify the study phase, 28,29,32,34,44,50,57,60,61,75,80,81,83,92,93,98,[106]…”